Primary Site >> Biliary tract Cancer
Gene >> IL2
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Propagation and characterization of lymphocytes infiltrating livers of patients with primary biliary cirrhosis and autoimmune hepatitis. PMID: 2351571 |
Ref: [LAK cell adoptive immunotherapy and its problems]. PMID: 1944194 |
Ref: MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth. PMID: 8797593 |
Ref: Effective adoptive immunotherapy by T-LAK cells retargeted with bacterial superantigen-conjugated antibody to MUC1 in xenografted severe combined immunodeficient mice. PMID: 9661899 |
Ref: A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma. PMID: 11845258 |
Ref: A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity. PMID: 12594573 |
Ref: A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells. PMID: 14648071 |
Ref: Combining cetuximab with killer lymphocytes synergistically inhibits human cholangiocarcinoma cells in vitro. PMID: 22641659 |
Ref: Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomography. PMID: 23076270 Ref: Synergistic effect between Juzen-taiho-to, a Japanese traditional herbal medicine, and gemcitabine single-agent chemotherapy for advanced biliary tract cancer. PMID: 23215436 |
Ref: Mesothelin-targeting chimeric antigen receptor-modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma. PMID: 28381173 Ref: The Diagnostic Roles of Cytokines in Hepatobiliary Cancers. PMID: 29410961 |